Moderna, Inc. (MRNA) CEO Stéphane Bancel on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/07/21
Covid vaccine makers' shares seesaw after Biden administration says it will back patent waiversCNBC • 05/06/21
Vaccine Stocks Pare Deep Losses As Angela Merkel Opposes Waiving PatentsInvestors Business Daily • 05/06/21
Moderna's first-ever profit and billion-dollar quarter is dampened by COVID-19 vaccine patent proposalMarket Watch • 05/06/21
Will Moderna (MRNA) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research • 05/06/21
Moderna Stock Moves After Q1 Print: Technical Levels For The COVID-19 Vaccine PlayBenzinga • 05/06/21
Moderna, Pfizer drop after US backs proposal to lift patent protection for COVID-19 vaccines to boost supplyProactive Investors • 05/06/21
Moderna Says Covid-19 Vaccine Is 96% Effective In Teenagers, Will File For Full FDA ApprovalForbes • 05/06/21
Moderna CEO expects more Covid variants to emerge in coming months: 'This virus is not going away'CNBC • 05/06/21
Moderna Stock Drops As Q1 Sales Fails To Meet Expectations; Anticipates $19.2B In FY21 Product SalesBenzinga • 05/06/21
Moderna says its COVID-19 vaccine has a 96% efficacy rate in teens who have received one shotMarket Watch • 05/06/21
Coronavirus: Moderna says tweaked vaccine works against variants, two BioNTech/Pfizer doses give 95% protectionProactive Investors • 05/06/21
Moderna reports $1.7 billion in COVID-19 vaccine sales, posts first profit everMarket Watch • 05/06/21
Moderna turns around negative first-quarter earnings per share as revenue surgesMarket Watch • 05/06/21